Corcept Therapeutics, Inc. (CORT)
123.20
+0.95
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
123.20
0.00 (0.00%)
After-Hours: 19:56
Corcept Therapeutics Total Liabilities (Quarterly) : 182.93M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 182.93M |
| March 31, 2026 | 176.89M |
| December 31, 2025 | 190.22M |
| September 30, 2025 | 191.70M |
| June 30, 2025 | 165.93M |
| March 31, 2025 | 163.17M |
| December 31, 2024 | 160.96M |
| September 30, 2024 | 145.42M |
| June 30, 2024 | 118.31M |
| March 31, 2024 | 108.07M |
| December 31, 2023 | 114.81M |
| September 30, 2023 | 132.34M |
| June 30, 2023 | 103.01M |
| March 31, 2023 | 88.26M |
| December 31, 2022 | 81.59M |
| September 30, 2022 | 59.89M |
| June 30, 2022 | 54.04M |
| March 31, 2022 | 60.31M |
| December 31, 2021 | 47.95M |
| September 30, 2021 | 45.17M |
| June 30, 2021 | 45.80M |
| March 31, 2021 | 41.60M |
| December 31, 2020 | 48.39M |
| September 30, 2020 | 44.44M |
| June 30, 2020 | 44.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 36.00M |
| December 31, 2019 | 41.13M |
| September 30, 2019 | 32.65M |
| June 30, 2019 | 30.63M |
| March 31, 2019 | 34.46M |
| December 31, 2018 | 35.81M |
| September 30, 2018 | 40.21M |
| June 30, 2018 | 30.87M |
| March 31, 2018 | 27.75M |
| December 31, 2017 | 29.57M |
| September 30, 2017 | 24.37M |
| June 30, 2017 | 20.39M |
| March 31, 2017 | 25.76M |
| December 31, 2016 | 27.37M |
| September 30, 2016 | 31.68M |
| June 30, 2016 | 31.18M |
| March 31, 2016 | 32.74M |
| December 31, 2015 | 33.44M |
| September 30, 2015 | 34.90M |
| June 30, 2015 | 36.83M |
| March 31, 2015 | 37.65M |
| December 31, 2014 | 38.02M |
| September 30, 2014 | 38.48M |
| June 30, 2014 | 40.94M |
| March 31, 2014 | 43.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 51.45M |
| Liquidia Corp. | 326.80M |
| Indivior Pharmaceuticals, Inc. | 1.441B |
| Crinetics Pharmaceuticals, Inc. | 129.92M |
| Forum Markets, Inc. | 31.23M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 888.70M |
| Shareholders Equity (Quarterly) | 705.78M |
| Debt to Equity Ratio | 0.0133 |
| Current Ratio | 2.830 |
| Net Debt Paydown Yield | -0.01% |